After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Mylan Inc.
The EpiPen-maker is looking to cut less than 10% of its workforce, a spokeswoman confirmed Tuesday.
Small-caps could also benefit from abating tax-loss selling.
The drug company declined Sen. Chuck Grassley's request to testify on pricing practices later this month.
Famed short-seller says drugmaker at risk of a government crackdown.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.